Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2009
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junctionDavid J Adelstein, Thomas W Rice, Lisa A Rybicki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancerCristina P Rodriguez, David J Adelstein, Thomas W Rice, et al.Head & Neck|August 16, 2008
Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapyCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.Cancer|April 19, 2018
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trialMargaret K Guerriero, Mary W Redman, Kelsey K Baker, et al.Laryngoscope Investigative Otolaryngology|April 18, 2022
A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancerAndrew J Frankart, Nooshin Hashemi Sadraei, Brad Huth, et al.International Journal of Particle Therapy|January 5, 2026
Outcomes After Fast Neutron Therapy for Locally Advanced Base of Tongue Adenoid Cystic CarcinomaAnthony K Heng, August Anderson, Robert D Stewart, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice GuidelineShlomo A Koyfman, Nofisat Ismaila, Doug Crook, et al.The Laryngoscope|December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinomaBruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.Head & Neck|November 22, 2022
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostatCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.Head & Neck|July 14, 2023
Radiation therapy for low- and high-risk perineural invasion in head and neck cutaneous squamous cell carcinoma: Clinical outcomes and patterns of failureTheodore A Gobillot, Matthew Greer, Upendra Parvathaneni, et al.Pageof 8